|
Volumn 97, Issue 3, 2001, Pages 409-416
|
Prognostic value of DNA quantification in early epithelial ovarian carcinoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
PROTEIN P53;
ADULT;
AGED;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURVIVAL;
DNA CONTENT;
DNA DETERMINATION;
FEMALE;
FLOW CYTOMETRY;
GENE OVEREXPRESSION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
MAJOR CLINICAL STUDY;
MULTIVARIATE ANALYSIS;
ONCOGENE C ERB;
OVARY CARCINOMA;
PRIORITY JOURNAL;
PROGNOSIS;
RETROSPECTIVE STUDY;
ADULT;
AGED;
AGED, 80 AND OVER;
CARCINOMA;
DISEASE-FREE SURVIVAL;
DNA, NEOPLASM;
FEMALE;
FLOW CYTOMETRY;
FOLLOW-UP STUDIES;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENES, ERBB-2;
HUMANS;
IMMUNOHISTOCHEMISTRY;
MEDICAL RECORDS;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
ODDS RATIO;
OVARIAN NEOPLASMS;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
RETROSPECTIVE STUDIES;
SPAIN;
SURVIVAL ANALYSIS;
TUMOR SUPPRESSOR PROTEIN P53;
|
EID: 0035120163
PISSN: 00297844
EISSN: None
Source Type: Journal
DOI: 10.1016/S0029-7844(00)01176-5 Document Type: Article |
Times cited : (13)
|
References (34)
|